Clinical Trial Update: Efficacy of Endothelin Receptor Antagonism in Coronary Artery Spasm [Phase 2, Phase 3]

View source ↗

Summary

This clinical-trial update reports on the efficacy evaluation of endothelin receptor antagonism for coronary artery spasm across Phase 2 and Phase 3, sponsored …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Spasm

Drugs mentioned

• Endothelin receptor antagonist (unspecified)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Coronary Spasm | Phase 2, Phase 3 | Status: ENROLLING_BY_INVITATION